Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.50
Ask: 38.80
Change: -0.10 (-0.26%)
Spread: 0.30 (0.779%)
Open: 38.60
High: 38.80
Low: 38.50
Prev. Close: 38.60
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

11 Dec 2017 08:02

RNS Number : 8760Y
Accrol Group Holdings PLC
11 December 2017
 

11 December 2017

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Accrol Group Holdings plc

(AIM: ACRL)

 

Directors' Dealings

 

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, is pleased to announce that certain directors of Accrol have, pursuant to the Placing (as described in the Company's announcement of 20 November 2017 titled "Proposed Placing of £18m and Lifting of Suspension"), in aggregate purchased 400,000 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 50p per Ordinary Share as set out below.

 

 

 

 

 

Name

 

 

 

 

Title

 

 

 

Number of Shares

 

 

 

Value of Shares

 

 

 

Resulting Shareholding

Percentage of Enlarged Share Capital

 

 

 

 

 

 

Peter Cheung

Chairman

50,000

£25,000

661,683

0.51%

Gareth Jenkins

CEO

100,000

£50,000

100,000

0.08%

Steve Hammett

Non-executive Director

40,000

£20,000

40,000

0.03%

Joanne Lake

Non-executive Director

10,000

£5,000

35,000

0.03%

Dan Wright

Non-executive Director

200,000

£100,000

200,000

0.16%

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

i) Peter Cheung

ii) Gareth Jenkins

iii) Steve Hammett

iv) Joanne Lake

v) Dan Wright

2

Reason for the notification

a)

Position/status

i) Chairman

ii) Chief Executive Officer

iii) Non-executive Director

iv) Non-executive Director

v) Non-executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

50p

 

Volume(s)

i) 50,000

ii) 100,000

iii) 40,000

iv) 10,000

v) 200,000

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

11 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

Enquiries:

 

Accrol Group Holdings plc Tel: +44 (0) 1254 278 844

Gareth Jenkins, CEO

James Flude, Finance Director

 

Zeus Capital Limited (Nominated Adviser & Broker)

Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512

Dominic King / John Goold Tel: +44 (0) 203 829 5000

 

Belvedere Communications Limited Tel: +44 (0) 203 567 0510

Cat Valentine (cvalentine@belvederepr.com) Mob: +44 (0) 7715 769 078

Kim van Beeck (kvbeeck@belvederepr.com) Mob: +44 (0) 7477 967 446

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFMMGZVRZGNZM
Date   Source Headline
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1
20th Jan 20207:00 amRNSRegulatory investigation closed
15th Jan 20207:00 amRNSTR-1
14th Jan 20207:00 amRNSTR-1
7th Jan 20207:00 amRNSHalf Year Results
16th Dec 20197:00 amRNSTR-1
13th Nov 201912:11 pmRNSTR-1
22nd Oct 201911:30 amRNSResult of AGM
17th Oct 20198:00 amRNSVesting of FY2019 Share Option Awards
26th Sep 20198:30 amRNSNotice of AGM
6th Sep 201911:52 amRNSTR-1
3rd Sep 20197:00 amRNSAudited Final Results
10th Jun 20197:00 amRNSTrading Update and Notice of Results
25th Apr 20194:32 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSSenior Management Change
27th Mar 201910:20 amRNSRegulatory Investigation Update
11th Feb 20194:35 pmRNSDirector/PDMR Shareholding
6th Feb 20193:03 pmRNSHolding(s) in Company
22nd Jan 20195:15 pmRNSDirector's Dealing
22nd Jan 20199:05 amRNSSecond Price Monitoring Extn
22nd Jan 20199:00 amRNSPrice Monitoring Extension
22nd Jan 20197:01 amRNSHalf Year Results
22nd Jan 20197:00 amRNSBoard Change and Senior Management Appointment
21st Jan 20192:20 pmRNSRegulatory Investigation
10th Jan 20191:35 pmRNSHolding(s) in Company
8th Jan 201911:05 amRNSSecond Price Monitoring Extn
8th Jan 201911:00 amRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSTrading Update
23rd Nov 20187:00 amRNSAccrol Group to present at Mello London
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.